about
Pulmonary arterial compliance: How and why should we measure it?A review of wave mechanics in the pulmonary artery with an emphasis on wave intensity analysisRight-to-left shunt with hypoxemia in pulmonary hypertension.Oxidative profiling of the failing right heart in rats with pulmonary hypertensionEchocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertensionAssessment of daily life physical activities in pulmonary arterial hypertension.Impedance in isolated mouse lungs for the determination of site of action of vasoactive agents and disease.Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hypertension patients scheduled for pulmonary thromboendarterectomy: Is schistosomiasis hypertension an important confounding factor?Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injuryExperience with exercise right heart catheterization in the diagnosis of pulmonary hypertension: a retrospective study.Pulmonary vascular pressure profiles in broilers selected for susceptibility to pulmonary hypertension syndrome: age and sex comparisons.Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence.Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by AdenosineSafety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data.Assessment of N-terminal prohormone B-type natriuretic peptide as a measure of vascular and ventricular function in pediatric pulmonary arterial hypertensionPulmonary arterial hypertension: new insights and new hope.Wall shear stress is decreased in the pulmonary arteries of patients with pulmonary arterial hypertension: An image-based, computational fluid dynamics study.Evaluation of right atrial function using right atrial speckle tracking analysis in patients with pulmonary artery hypertension.Serotonin-mediated protein carbonylation in the right heart.Hemodynamic predictors of mortality in adults with sickle cell diseaseArterial pulmonary hypertension in noncardiac intensive care unit.Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension.Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment.Reversal of abnormal cardiac parameters following mitral valve replacement for severe mitral stenosis in relation to pulmonary artery pressure: A retrospective study of noninvasive parameters - Early and late pattern.The management of acute pulmonary arterial hypertension.Mechanics and function of the pulmonary vasculature: implications for pulmonary vascular disease and right ventricular function.Pulmonary hypertension and its management in patients undergoing non-cardiac surgery.Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.Heat stress is associated with reduced health status in pulmonary arterial hypertension: a prospective study cohort.Pulmonary Hypertension in Children - a Practical Approach.Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in TaiwanNovel 24-h ovine model of brain death to study the profile of the endothelin axis during cardiopulmonary injury.Three-wall segment (TriSeg) model describing mechanics and hemodynamics of ventricular interaction.Hemodynamic assessment of pulmonary hypertension.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Intensive care management of pulmonary hypertension.Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.Sleep findings and predictors of sleep desaturation in adult cystic fibrosis patients.Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients.
P2860
Q26771318-1F941A32-0776-4384-BFBA-1F0F238491C9Q28079995-11214960-DBFD-46C9-8A87-488A9F848736Q33425021-3A6545CC-0C9B-478D-BCB3-C11454C5B589Q33637652-DDEEC4D3-2CCE-4470-9654-0A83E9959333Q33968341-DABADE59-89EC-4B6D-AFDF-E9137A821166Q34081843-13F99E82-22DD-4980-893A-469725888D08Q34383834-F9565F10-9135-4C7B-989B-F44E65A95ADEQ34394040-9CBA2711-25F5-4AF5-929B-55692BA5D344Q34402389-20B84DFD-6B45-4202-98A2-A93785B523BDQ34410414-F4BBB4AD-FEFB-4AF1-93B9-8625C9ECAE95Q34764116-545E415B-E5F0-44F7-8296-A2F6D43BC53CQ36192759-089FF9D6-3B03-4ADD-9A03-D01536D325B1Q36215888-D381C14C-D931-4549-B499-0638B2833BD5Q36302117-30CD907E-5F11-471C-8F1D-1E62A57AFF84Q36352093-178D951A-B2FF-4705-91E2-B74C2A695EE9Q36372605-5A2ABAB4-2F71-4860-9DCD-2372924D1912Q36563575-A2D4EB35-E411-416A-AFFA-50E8D9514219Q36656133-0A5D8147-805B-41AE-8B15-D76BB8B8277AQ36951874-D1D7C973-CA30-4DAD-8ADD-AA7E59844B5EQ36999803-958965B2-6405-46FE-80F0-B9319578E7C9Q37019853-E78E4E72-4D79-4BCB-9506-8A61AFE0B15AQ37201770-6AB87D4B-91DD-4173-B0AC-2FC459812F9BQ37354098-FF3AD5CA-EBC8-4F07-9BD4-4EB29C5A3997Q37548919-12538A54-CF23-4FE6-A900-56A316D3EC97Q37726022-0B954F6C-CBA8-42B0-8EDA-7D10F39A5320Q37766261-08915678-01A7-4A4B-8375-A1B8D2771E73Q38111289-80D0DF10-5595-4C6F-BD52-332E44B9660DQ38255425-FBE93388-1CDD-49E4-8210-92A524E33944Q38368957-25B80DE3-AA24-435A-83E8-23A5B86A0FE5Q40190406-C31848AE-3567-4A02-8B48-726A8DBF5AF8Q41029573-20A3E316-F7C3-42A5-B69E-22493582B267Q41412846-E71C484F-A0EE-4BA0-B7FA-AA0774374ADDQ41669738-BC134FF0-3735-4B80-AC08-52B3DBAB2394Q41989846-D9443E40-823F-4B13-8B7F-A10AF584E11EQ42578910-2A8A2C3F-0B40-49AF-99BE-1624D49CE7AFQ42585448-9D549731-3C57-4D72-B54E-EF72E7C1899DQ42754235-B5723913-1942-4AA4-B4D5-3F9A774BCBF1Q43218254-12F5DE7B-A482-4139-90F4-999B20B7577AQ43409739-7861C3C9-A6B9-45BF-A464-9A3DD1A53B70Q44516763-9D26D4E1-9DF4-49D2-B2EE-8646C99F7999
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Haemodynamic evaluation of pulmonary hypertension.
@ast
Haemodynamic evaluation of pulmonary hypertension.
@en
type
label
Haemodynamic evaluation of pulmonary hypertension.
@ast
Haemodynamic evaluation of pulmonary hypertension.
@en
prefLabel
Haemodynamic evaluation of pulmonary hypertension.
@ast
Haemodynamic evaluation of pulmonary hypertension.
@en
P2093
P1476
Haemodynamic evaluation of pulmonary hypertension
@en
P2093
S Brimioulle
Y Lecarpentier
P304
P356
10.1183/09031936.02.00068002
P577
2002-11-01T00:00:00Z